Maraviroc - Therapy for Treatment of HIV Infection, No Country
Key Data:
Drug (brand/generic)
Maraviroc
Company/Licensee
Pfizer
Therapy Class
CCR5 receptor antagonist
Product Description
Blocks the CCR5 co-receptor on host CD4-T cells
Current Indication
Treatment of HIV as part of background HIV therapy
Market Sector
Anti-infectives
Development Status
Approved US and Europe
